Skip to main content
LKFT logo
LKFT
(NASDAQ)
Lakefront Biotherapeutics NV
$29.23-- (--)
Loading... - Market loading

Lakefront Biotherapeutics NV (LKFT) Stock Price & Financial Analysis

Lakefront Biotherapeutics NV Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.92 - $29.47
52-Week High$37.78
52-Week Low$26.42
Open$29.02
Volume96.05K
Average Volume (3M)173.32K
Market Cap1.93B
Shares Outstanding65.87M
P/E Ratio (TTM)3.49
Price to Sales (P/S)1.63
Price to Book (P/B)0.52
EV/EBITDA3.46
Revenue (TTM)1.19B
Net Income (TTM)557.53M
Free Cash Flow (TTM)-354.96M
EPS (TTM)$8.46
Profit Margin46.83%
Operating Margin57.14%
Return on Equity (ROE)15.02%
Debt to Equity0.00
50-Day MA$28.62
200-Day MA$31.21
52-Week Change-3.46%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Lakefront Biotherapeutics NV

What is the current stock price for LKFT?

As of the latest trading session, LKFT stock trades at $29.23. The 52-week range is $26.42–$37.78, with a day range of $28.92–$29.47.

What is the P/E ratio for LKFT?

Lakefront Biotherapeutics NV's trailing P/E ratio is 3.5, meaning investors pay $3.5 for every $1 of annual earnings. Lakefront Biotherapeutics NV operates in the Healthcare sector.

Does LKFT pay dividends?

Lakefront Biotherapeutics NV does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LKFT?

Analyst ratings and recommendations for LKFT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LKFT?

Lakefront Biotherapeutics NV's market capitalization is $1.93B, classifying it as a small-cap company. Lakefront Biotherapeutics NV operates in the Healthcare sector within the Biotechnology industry.